Close Menu

NEW YORK (GenomeWeb) – Three co-founders of 10X Genomics have prevailed in an arbitration dispute brought against them by Bio-Rad Laboratories, 10X Genomics said today.

According to 10X, Bio-Rad brought a claim before the American Arbitration Association in September of 2014, alleging that the three company founders — Serge Saxonov, Benjamin Hindson, and Kevin Ness — had breached certain contractual non-compete, non-solicitation, and confidentiality obligations they allegedly owed to Bio-Rad after it acquired Quantalife in 2011, where all three worked at the time.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.